Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 6 of 6 for “"MCAD deficiency"”.

  1. Measuring Core Outcomes from Metabolic Chart-Abstracted Data for Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency

    … pediatric medium-chain acyl-CoA dehydrogenase (MCAD) deficiency requires sustainable and integrated measurement of priority outcomes. Methods: From an existing Canadian cohort study, we evaluated the quality of metabolic clinic chart-abstracted data for measuring core outcomes for pediatric MCAD …

    ottawa-retro Repository record for Measuring Core Outcomes from Metabolic Chart-Abstracted Data for Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency (opens in a new tab)

  2. A Forensic Marker for a Genetic Disease Often Misdiagnosed as Sudden Infant Death Syndrome (SIDS)

    … with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, an inborn error of fatty acid oxidation. Blood and tissue samples from a large cohort of SIDS victims were analyzed for the presence of dodecanoic acid (C₁₂) by gas chromatography. A subgroup of these cases had a significantly …

    unt Repository record for A Forensic Marker for a Genetic Disease Often Misdiagnosed as Sudden Infant Death Syndrome (SIDS) (opens in a new tab)

  3. I. Synthesis of Myocardial Imaging Agents for Diagnosis of MCAD Deficiency. II. Synthesis of [fluorine-18] Fluoroaryl Estrogens as Receptor Based Tumor Imaging Agents for Breast Cancer

    The synthesis of a (fluorine-18) fluoroaryl estrogen in no-carrier-added form requires the use of ($\sp{18}$F) F$\sp-$. A great amount of effort has been made toward incorporation of ($\sp{18}$F) F$\sp-$onto an electron-rich aromatic ring, but none have found general application. Several strategies …

    uiuc Repository record for I. Synthesis of Myocardial Imaging Agents for Diagnosis of MCAD Deficiency. II. Synthesis of [fluorine-18] Fluoroaryl Estrogens as Receptor Based Tumor Imaging Agents for Breast Cancer (opens in a new tab)

  4. Guidance and Practice in the Diagnosis and Management of Two Rare Inherited Metabolic Diseases

    … including medium-chain acyl-CoA dehydrogenase (MCAD) deficiency and very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency. Newborn screening has also expanded the spectrum of disease severity for MCAD and VLCAD deficiencies to include a higher proportion of milder cases, raising questions …

    ottawa-retro Repository record for Guidance and Practice in the Diagnosis and Management of Two Rare Inherited Metabolic Diseases (opens in a new tab)

  5. Estimating Screening Results Following the Introduction of Next-generation Sequencing Into Newborn Screening

    … (PKU) and medium-chain acyl-CoA dehydrogenase (MCAD) deficiency; and a query of genetic compendia for variants of genes associated with the two disorders. Results: The introduction of T-NGS into NBS may reduce nearly 80% of false positives that are generated using the current screening approach. …

    ottawa-retro Repository record for Estimating Screening Results Following the Introduction of Next-generation Sequencing Into Newborn Screening (opens in a new tab)

  6. Biochemical studies on the physiopathology of MCAD, LCHAD and MTP deficiencies in human fibroblasts and rodent tissues : evidence of disruption of redox and energy homeostasis by accumulated metabolites

    The medium chain acyl-CoA dehydrogenase (MCAD) deficiency is a fatty acid oxidation disorder (FAOD) biochemically characterized by accumulation of medium-chain acylcarnitines (MCAC) in tissues and biological fluids of affected individuals. The clinical presentation includes neurological symptoms as …

    brazil-ufrgs Repository record for Biochemical studies on the physiopathology of MCAD, LCHAD and MTP deficiencies in human fibroblasts and rodent tissues : evidence of disruption of redox and energy homeostasis by accumulated metabolites (opens in a new tab)